Pancreatic islet cells are small clusters of hormone-producing cells scattered throughout the pancreas, and they serve as the body’s primary glucose-sensing and blood-sugar-regulating machinery. Each cluster, called an islet of Langerhans, contains several distinct cell types that work together to release hormones like insulin and glucagon in precise, coordinated pulses. Though islets make up only about one to two percent of the pancreas by volume, their failure is the central event in both type 1 and type 2 diabetes, making them one of the most medically consequential bits of tissue in the human body.
What Islets Look Like and How They Are Arranged
An islet is a tiny ball of cells, roughly 50 to 500 micrometers across, embedded within the larger mass of digestive-enzyme-producing tissue that makes up most of the pancreas. The human pancreas contains somewhere around a million of these clusters, though estimates vary. They are not evenly distributed. Three-dimensional mapping of healthy human pancreases has shown that islets tend to cluster together in the head of the organ and gradually become more dispersed moving toward the tail.1Scientific Reports. A 3D map of the islet routes throughout the healthy human pancreas Other work has reported that islet density is actually more than two-fold higher in the tail compared to the head and body, which speaks to how much individual variation and methodological differences can shape these measurements.2PubMed Central. Regional differences in islet distribution in the human pancreas–preferential beta-cell loss in the head region in patients with type 2 diabetes
If you grew up seeing diagrams of islets as tidy spheres with a core of one cell type and a shell of another, those diagrams were drawn from mice. In rodent islets, insulin-producing beta cells sit in a central core, with glucagon-producing alpha cells and somatostatin-producing delta cells forming a neat outer mantle.3PubMed Central. Islet architecture: A comparative study Human islets look nothing like this. Confocal microscopy studies have found that in people, beta cells, alpha cells, and delta cells are all scattered throughout the islet with no obvious anatomical subdivisions. About 71 percent of human beta cells sit in direct contact with other endocrine cell types, suggesting a level of cell-to-cell communication that is simply not present in mouse islets.4PubMed Central. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function Human islets also have proportionally fewer beta cells and more alpha cells than mouse islets, and they contain smooth-muscle-lined blood vessels that rodent islets lack.5PubMed. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes This matters because a huge amount of diabetes research has been done in mice, and findings about islet behavior do not always translate cleanly to humans.
Beta Cells and Insulin Secretion
Beta cells are the workhorses of the islet. They sense rising blood glucose and respond by releasing insulin, the hormone that tells your muscles, liver, and fat tissue to pull glucose out of the bloodstream. The mechanism connecting glucose levels to insulin release is elegant: when glucose enters a beta cell, it gets broken down through a series of metabolic steps that produce ATP, the cell’s energy currency. As glucose rises, the ratio of ATP to ADP inside the cell climbs sharply. That shift closes specific ion channels in the cell membrane, which changes the cell’s electrical charge, triggers calcium to flood in, and ultimately causes tiny insulin-packed granules to fuse with the cell surface and dump their contents into the bloodstream.6PubMed Central. A pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell
Insulin release comes in two distinct waves. The first phase lasts only a few minutes and involves a small pool of granules that are already docked at the cell surface, ready to go. The second phase is slower and sustained: the cell has to physically move additional insulin granules from deeper inside the cell up to the membrane before they can be released. This second wave is driven exclusively by nutrient signals and requires active rearrangement of the cell’s internal scaffolding.7PubMed Central. Mechanisms of biphasic insulin-granule exocytosis – roles of the cytoskeleton, small GTPases and SNARE proteins The loss of that first-phase burst is one of the earliest detectable signs of developing type 2 diabetes, often appearing years before a person’s fasting blood sugar looks abnormal on a standard lab test.
Alpha Cells and Glucagon
Alpha cells do roughly the opposite of what beta cells do. When blood sugar drops, alpha cells release glucagon, a hormone that travels to the liver and tells it to dump stored glucose into the bloodstream. In the short term, glucagon works primarily by breaking down glycogen, the liver’s carbohydrate reserve. During longer fasts, it also promotes the creation of new glucose from non-carbohydrate sources.8PubMed Central. Physiologic action of glucagon on liver glucose metabolism Glucagon’s job is essentially to prevent you from passing out between meals or during exercise by keeping a floor under your blood sugar.
The way alpha cells know when to fire is itself a fascinating piece of biology. At low glucose levels, specific potassium channels in the alpha cell membrane sit at just the right level of activity to let sodium and calcium channels open in rapid succession, generating electrical spikes that trigger glucagon release.9Journal of Endocrinology. Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes When glucose rises, the picture changes: increased glucose metabolism inside the alpha cell actually lowers the rate of fatty acid burning in the mitochondria, which paradoxically reduces ATP production and causes the cell to quiet down electrically, shutting off glucagon secretion.10Diabetes. Glucose Controls Glucagon Secretion by Regulating Fatty Acid Oxidation in Pancreatic α-Cells So both alpha and beta cells use glucose metabolism as their sensor, but the downstream wiring produces opposite outputs.
Delta Cells, Epsilon Cells, and the Rarer Players
Beyond the big two, islets contain at least three other endocrine cell types. Delta cells produce somatostatin, a hormone that acts as a local brake on both insulin and glucagon secretion. Signals released by neighboring alpha and beta cells amplify somatostatin release from delta cells, and the somatostatin then feeds back to suppress both of those neighbors. This creates a self-limiting loop: a burst of insulin or glucagon secretion triggers somatostatin, which dials everything back down.11PubMed Central. The somatostatin-secreting pancreatic δ-cell in health and disease
The somatostatin system has some indirect tricks as well. Even though somatostatin receptors are not found directly on beta cells in some experimental models, blocking those receptors on alpha cells during nutrient stimulation still led to increased insulin release, because the freed-up alpha cells released more glucagon, which in turn stimulated beta cells.12PubMed Central. Somatostatin Receptors Shape Insulin and Glucagon Output within the Pancreatic Islet through Direct and Paracrine Effects The practical implication is that somatostatin does not just suppress individual cells; it shapes the entire conversation within the islet.
PP cells (also called F cells) produce pancreatic polypeptide, a hormone involved in regulating appetite and digestive enzyme secretion. Epsilon cells are the rarest of the group. They produce ghrelin, the “hunger hormone” better known for its role in the stomach. In adults, epsilon cells are scarce: quantitative analysis has found an average of roughly one epsilon cell per islet, accounting for only about 0.14 percent of islet cell volume.13Springer Link / Diabetologia. Ghrelin-producing epsilon cells in the developing and adult human pancreas Epsilon cells appear to be more prominent during fetal development and then recede in number after birth. Their precise role in the adult islet is still an open question.
How Islet Cells Talk to Each Other
Individual beta cells, if plucked out and studied alone, are not very good at their job. They release insulin in erratic, uncoordinated dribbles. What makes them effective is the fact that they work as a synchronized team, and the key infrastructure for that coordination is a network of gap junctions built from a protein called connexin-36. These tiny channels directly connect the interiors of neighboring beta cells, allowing ions and small molecules to pass between them. During glucose stimulation, this coupling produces coordinated waves of calcium that sweep across the islet, driving pulsatile insulin release.14Biophysical Journal. Spatiotemporal Calcium Dynamics in Islets of Langerhans Heterogeneity and Gap Junction Coupling
When these gap junctions are knocked out experimentally in mice, islets lose the ability to produce regular calcium oscillations entirely, and basal insulin release goes haywire.15Diabetes. Loss of Connexin36 Channels Alters β-Cell Coupling, Islet Synchronization of Glucose-Induced Ca2+ and Insulin Oscillations, and Basal Insulin Release The result is inappropriate insulin leaking out when glucose is low and a blunted, disorganized response when glucose is high. This finding helps explain why islets cannot simply be replaced by scattering individual beta cells around the body; the cells need their neighbors and the physical connections between them to function properly.
On top of gap junctions, islet cells communicate through paracrine signaling, meaning hormones released by one cell type wash over their immediate neighbors and alter their behavior. Insulin from beta cells suppresses alpha cell activity. Glucagon from alpha cells amplifies beta cell secretion. Somatostatin from delta cells inhibits both. The autonomic nervous system adds another layer: parasympathetic nerve signals boost insulin secretion, while sympathetic signals suppress it, which is part of the reason your blood sugar rises during acute stress.16PubMed. Autonomic regulation of islet hormone secretion–implications for health and disease
The Blood Supply That Makes It All Work
Islets receive a disproportionately rich blood supply relative to their size. The capillary network running through each islet is dense and highly fenestrated, meaning the vessel walls are perforated with tiny pores that allow rapid exchange of nutrients and hormones.17PubMed. The vascular architecture of the pancreatic islets: A homage to August Krogh This design makes sense given what islets need to do: they have to detect changes in circulating glucose almost in real time and dump their hormones into the bloodstream just as quickly. A sluggish blood supply would mean delayed sensing and delayed response, which would make tight glucose control impossible. The importance of this vasculature becomes painfully clear during islet transplantation, when re-establishing an adequate blood supply to the transplanted cells is one of the biggest early challenges.
What Goes Wrong in Diabetes
Type 1 and type 2 diabetes both center on islet cell dysfunction, but the underlying problems are fundamentally different.
In type 1 diabetes, the immune system identifies beta cells as foreign and destroys them. The attack is carried out primarily by T cells, with CD4 cells orchestrating the assault and CD8 cells delivering the killing blow directly.18PubMed Central. Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes By the time a person develops symptoms, a large fraction of their beta cell mass has already been destroyed.19PubMed Central. T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes Alpha cells are generally spared, which creates the double problem of too little insulin and, in many cases, poorly regulated glucagon, both of which push blood sugar upward.
Type 2 diabetes involves a slower, more insidious process. Chronically elevated blood sugar and high levels of circulating fatty acids, especially saturated fats, gradually poison beta cells through a combination of stress pathways.20PubMed Central. Lipotoxicity and β-Cell Failure in Type 2 Diabetes: Oxidative Stress Linked to NADPH Oxidase and ER Stress Prolonged exposure to high glucose suppresses the expression of genes critical for beta cell identity and insulin production while simultaneously ramping up fat-building pathways inside the cell.21Journal of Cell Science. ER stress and SREBP-1 activation are implicated in β-cell glucolipotoxicity The combined metabolic stress triggers oxidative damage, dysfunction of the cell’s protein-folding machinery, and impaired autophagy, the cell’s internal recycling system.22PubMed Central. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes
Another contributor specific to humans is amyloid buildup. Human beta cells produce a protein called islet amyloid polypeptide (IAPP) alongside insulin. Over time, especially under metabolic stress, IAPP can misfold and aggregate into toxic clumps within the islet.23PubMed Central. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells Normally, the cell’s autophagy system clears these aggregates before they cause harm, but when autophagy is impaired, toxic oligomers of IAPP accumulate and damage beta cells.24JCI Insight. Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity This is another way that human islets differ from rodent models: mice produce a version of IAPP that does not form amyloid, so this entire pathological process is invisible in standard mouse studies.
Islet Transplantation and Its Limits
Since the late 1990s, researchers have been transplanting donor islets into people with severe type 1 diabetes, typically infusing them into the liver’s portal vein. The landmark international trial of the Edmonton Protocol found that about 58 percent of recipients achieved insulin independence at some point after transplantation, but most of them needed insulin again within two years.25PubMed. International trial of the Edmonton protocol for islet transplantation
Longer follow-up data paint a more encouraging picture. A single-center study tracking 79 patients over a median of 13 years found that graft survival, measured by detectable C-peptide levels, was 86 percent at one year, 65 percent at five years, and still 47 percent at ten years. When patients received a higher dose of islets combined with optimized immunosuppression, the median graft survival stretched to nearly ten years, and 73 percent of that group achieved insulin independence.26The Lancet Diabetes & Endocrinology. Long-term outcomes of islet transplantation alone for type 1 diabetes: a single-centre retrospective cohort study Twenty-year follow-up data have confirmed the long-term safety of the procedure despite chronic immunosuppression, but two obstacles remain: there are not nearly enough donor pancreases to go around, and the immunosuppressive drugs carry their own risks.27PubMed Central. The Current Status of Allogenic Islet Cell Transplantation
Emerging Approaches to Replace or Regenerate Beta Cells
The donor shortage has pushed researchers toward lab-grown alternatives. One strategy uses induced pluripotent stem cells, essentially reprogrammed adult cells, to generate beta-like cells in the laboratory. The idea is to create a limitless supply of insulin-producing cells without needing donor organs.28PubMed Central. Stem Cell-Derived Beta-Cell Therapies: Encapsulation Advances and Immunological Hurdles in Diabetes Treatment Early-stage work with scaffold-based encapsulation has demonstrated that both human islets and stem-cell-derived beta-cell clusters can maintain high viability and produce a realistic biphasic insulin response when housed in porous gel matrices.29PubMed. Superporous agarose scaffolds for encapsulation of adult human islets and human stem-cell-derived β cells for intravascular bioartificial pancreas applications The encapsulation is intended to shield the cells from immune attack while still allowing glucose and insulin to pass through. Making this work reliably at scale, over years rather than weeks, is the hard part.
A completely different approach exploits the surprising plasticity of alpha cells. In animal models, when beta cells are destroyed, some alpha cells spontaneously begin producing insulin instead, effectively switching their identity. This transdifferentiation appears to depend on specific transcription factors that normally maintain each cell type’s identity, and glucagon itself seems to play a necessary signaling role in the switch.30PubMed Central. Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis The finding has been observed in both mice and zebrafish, suggesting this regenerative capacity is conserved across species.31PubMed Central. Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy Whether the same process can be safely and reliably triggered in human islets is still unknown, but it raises the tantalizing possibility of coaxing a patient’s own alpha cells into becoming new beta cells without transplanting anything at all.
How Islets Form During Development
In the embryo, the pancreas arises from a small bud of tissue in the developing gut. Islet cells and the enzyme-secreting cells that make up most of the adult pancreas share a common progenitor, but their fates diverge during a branching process of growth and differentiation that unfolds in three broad stages: an initial expansion of progenitor cells, a phase of lineage commitment and branching, and a final maturation period in which the organ remodels into its adult form.32PubMed Central. Transcription factor regulation of pancreatic organogenesis, differentiation and maturation
A key checkpoint in this process is the activation of a transcription factor called NGN3, which marks the moment a progenitor cell commits to becoming an endocrine (hormone-producing) cell rather than a digestive-enzyme-producing cell. NGN3 is unstable and rapidly broken down, and its levels need to be carefully regulated. Recent work has shown that a specific enzyme, USP7, stabilizes NGN3 and is essential for proper islet formation. When USP7 is knocked out in the embryonic mouse pancreas, islet formation drops dramatically and the animals develop high blood sugar as adults.33PubMed Central. USP7 controls NGN3 stability and pancreatic endocrine lineage development This finding has practical implications for stem-cell-based therapies, since the same molecular checkpoint governs how efficiently lab-grown cells can be steered toward a beta cell fate.
Islets Across the Animal Kingdom
Islet cells are not unique to mammals. Insulin- and glucagon-producing cells appear throughout vertebrate evolution, though their physical organization varies widely. In bony fish, for example, islet tissue can take surprisingly different forms. Some fish species have evolved a concentrated mass of islet tissue called a Brockmann body, which sits as a distinct organ near the gallbladder or spleen rather than being sprinkled through the pancreas the way it is in mammals. This structure appears to have evolved independently multiple times across different lineages of bony fish.34PubMed Central. Anatomy of the endocrine pancreas in actinopterygian fishes and its phylogenetic implications The recurring evolution of concentrated islet tissue in unrelated fish groups suggests there is strong selective pressure to keep glucose-sensing cells close together, whether they are scattered in a mammalian pancreas or bundled into a standalone organ in a fish. The fundamental job, reading blood sugar and adjusting it with opposing hormones, has remained remarkably consistent for hundreds of millions of years, even as the packaging has changed.